Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Plans Action After Losing Opioids Trial In New York
Israeli Firm Is Preparing ‘Swift’ Appeal And Continues To Pursue A Mistrial
Jan 05 2022
•
By
Dean Rudge
The case involved a novel theory of liability • Source: Shutterstock: New Africa
More from Legal & IP
More from Generics Bulletin